Comparison of Treximet & Imitrex as They Affect the Levels of Inflammatory Markers When the Patient is Actively Having a Migraine Headache

CompletedOBSERVATIONAL
Enrollment

30

Participants

Timeline

Start Date

December 31, 2009

Primary Completion Date

December 31, 2010

Study Completion Date

July 31, 2011

Conditions
Migraine
Interventions
DRUG

sumatriptan and Treximet

sumatriptan 100mg tablet when migraine is moderate or severe in intensity. Treximet 85/500mg tablet when migraine is moderate or severe in intensity.

Trial Locations (1)

49009

Westside Family Medical Center, PC, Kalamazoo

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

GlaxoSmithKline

INDUSTRY

lead

Gary E. Ruoff, M.D.

OTHER

NCT01916395 - Comparison of Treximet & Imitrex as They Affect the Levels of Inflammatory Markers When the Patient is Actively Having a Migraine Headache | Biotech Hunter | Biotech Hunter